Cyclophilin is a ubiquitous peptidyl prolyl cis/trans isomerase that plays critical roles in many biological processes. A number of cyclophilin inhibitors have been designed based on the structure of the immunosuppressant cyclosporin A. To discover inhibitors that have other structures, the authors established the high-throughput screening (HTS) method using FDSS6000 real-time fluorescence detector. The inhibitors identified with this HTS showed significant correlation with direct interaction as measured by surface plasmon resonance. This high-throughput assay system is a powerful tool for the discovery of peptidylprolyl isomerase inhibitors. (Journal of Biomolecular Screening 2009:419-424) Key words: peptidyl prolyl cis/trans isomerase, high-throughput screening, protease-coupled assay, cyclophilin, cyclosporin A cis/trans isomerization rate is extremely fast, with a half-life of 74 s at 10 °C. 6 Measuring the reaction at low temperature requires prolonged detection time. For example, the total running time to monitor PPIase activity on one 96-well microplate is about 30 min, 10 which is problematic for high-throughput screening (HTS). We have developed the HTS using an FDSS6000 real-time fluorescence detector (Hamamatsu Photonics, Hamamatsu City, Japan). This instrument has been used for cell-based assays of G-protein-coupled receptors (GPCRs) or calcium channels using fluorescent calcium dyes. It has a cooled CCD camera imaging system that is able to simultaneously collect the signals from each well of a microplate. In addition, the FDSS can detect signals at subsecond intervals.
INTRODUCTION
C YCLOPHILIN A (CYPA) CATALYZES THE CIS/TRANS ISOMERI-ZATION of peptidyl-prolyl bonds and acts as a molecular chaperone in protein folding, assembly, and transport processes. 1, 2 Cyclosporin A (CsA) inhibits the peptidyl-prolyl isomerase (PPIase) activity of CypA. 3, 4 CsA is an immunosuppressive drug and has potential therapeutic applications in the treatment of diseases such as asthma, psoriasis, atopic dermatitis, and rheumatoid arthritis. However, as a therapeutic agent, CsA has several undesirable side effects 5 that may be due to inhibition of calcineurin (CN). Efforts are under way to identify CsA analogs or small-molecule Cyp inhibitors that do not bind to CN. In general, PPIase activity has been assessed by assays based on protease-coupled isomer-specific proteolysis using tetrapeptide derivatives, Ala-Xaa-Pro-Yaa-para-nitro-anilide by UV-Vis spectroscopy 6 and 4-methylcoumaryl-7-amide (MCA) by fluorescence spectroscopy. 7, 8 The protease-free assay based on minor absorption coefficients of cis and trans conformers of tetrapeptide anilides remote from far UV peptide absorption has also been described. 9 To date, no room temperature protease-coupled PPIase assay has been reported, in part because the uncatalyzed spontaneous Technical Note Biacore T100, Sensor Chip CM5 (Series S), amine coupling kit, HBS-EP buffer, and anti-GST antibody were obtained from GE Healthcare Bio-Sciences (Tokyo, Japan). Biacore instruments are based on surface plasmon resonance (SPR) detection on gold surfaces and a microfluidic system for reagent handling.
PPIase assay optimization
Fluorogenic peptide substrate that had been proline isomerized was hydrolyzed by chymotrypsin, an isomer-specific protease. Then, 10 µL of assay buffer (25 mM HEPES, 100 mM NaCl [pH 7.0], 0.01% Triton-X100) containing PPIase inhibitors, 20 µL of assay buffer containing 125 µM chymotrypsin, and 20 µL of assay buffer containing 17.5 nM CypA were mixed immediately, and 3 µL of substrate solution (250 µM Suc-Ala-Ala-Pro-Phe-MCA in trifluoroethanol containing 480 mM LiCl) was then added and mixed immediately. The increase in 7-amino-4-methylcoumarin (AMC) liberated by proteolysis was monitored fluorometrically at an excitation λ ex = 365 nm and an emission λ em = 460 nm at 0.5-s intervals using an FDSS6000 real-time fluorescence detector. The time course of substrate hydrolysis of the trans conformer in the absence (CypA none) and presence of PPIase was used to calculate PPIase activity.
High-throughput screen for PPIase inhibitors
Briefly, 2 µL of 1-mM compounds dissolved in DMSO on 384-well plates was diluted by adding 18 µL assay buffer, using a Multidrop 384 dispenser (Thermo Electron, Waltham, MA). Then, 10 µL of prepared compounds was transferred, using CyBi Well 384/1536 (CyBio, Woburn, MA) into 384-well assay plates containing 20 µL of 125 µM chymotrypsin in each well. After adding 20 µL of 17.5 nM CypA using a Multidrop 384 dispenser, the assay plates were then placed to the FDSS6000. Using the FDSS 384-chip head under plate shaking conditions, 3 µL of substrate solution (250 µM Suc-Ala-Ala-Pro-Phe-MCA in trifluoroethanol containing 480 mM LiCl) was added. The increase in AMC was monitored at 0.5-s intervals using an FDSS6000 real-time fluorescence detector.
Data analysis
The Z′ factor was determined to use 4 parameters: the mean (µ) and standard deviation (SD) of both the positive (p) and negative (n) controls (µ p , SD p , µ n , SD n , respectively). The Z′ factor was defined as follows: 1 -3 × (SD p + SD n )/|µ p -µ n |.
The inhibition ratio was determined as follows. First, the background fluorescence intensity and/or autofluorescence of inhibitors were measured at 2 s before the addition of the substrate, and the background fluorescence was subtracted from the fluorescence measured. Second, the conversion ratio of substrate at 2.5 s after substrate injection was calculated (equation (1)).
Conversion ratio (%) = 100 × (FI (2.5 s) -FI (-2 s) )/(FI (60 s) -FI (-2 s) ), (1) where FI (60 s) is the final FI of the proteolytically produced AMC, FI (-2 s) is the FI at 2 s before substrate injection, and FI (2.5 s) is the FI of the proteolytically produced AMC at 2.5 s after substrate injection. By using the difference of the conversion ratio of substrate between spontaneous (CypA none) and CypA-catalyzing isomerization (CypA 7 nM) at 2.5 s after substrate injection, we determined the inhibition ratio (%) of inhibitors (equation (2)).
Inhibition ratio (%) = 100 × (conversion ratio (CypA 7 nM) -conversion ratio (inhibitor) )/(conversion ratio (CypA 7 nM) -conversion ratio (CypA none) ).
Hits (>50% inhibition) were retested by dose-response manner, and these data were fitted with a standard dose-response inhibition model using XLfit software (ID Business Solutions, Guildford, UK), and their IC 50 (50% inhibitory concentration) was estimated.
Determination of binding constants of CsA to CypA by SPR
Binding affinity experiments were performed using a Biacore T100 detector.
Immobilization of CypA. Immobilization of anti-GST antibodies to CM5 Sensor Chips was performed as described previously, 12 and CypA capture was performed by injecting GST-CypA over anti-GST antibodies at concentrations of 20 µg/mL in HBS-EP (10 mM HEPES [pH 7.4], 150 mM NaCl, 3 mM EDTA, 0.005% Tween-20) buffer for 10 min at a flow rate of 10 µL/min.
Binding experiments. Compounds diluted to 1 mM with 100% DMSO were mixed with 300-to 100,000-fold concentrated assay buffer and DMSO to yield 1-nM to 30-µM compounds in HBS-EP buffer with 1% DMSO (assay buffer). A typical analysis cycle consisted of a 120-s sample injection (30 µL/min), 180 s of buffer flow (dissociation phase), and a 30-s buffer injection to check for sample carryover. The flow cell temperature was set at 25 °C. Biacore T100 evaluation software (Version 1.1.1) was used for curve fitting of the entire inhibitor concentration series data set (global fit) using numerical calculations of the equation system.
RESULTS AND DISCUSSION

Development of HTS for the PPIase assay
We used the Ala-Ala-Pro-Phe peptide as a substrate for CypA PPIase assays. The assays were performed at room temperature using an FDSS6000 real-time fluorescence detector.
Using this detector, we developed a method to monitor the difference between CypA-catalyzed and spontaneous cis/trans isomerization rates at nearly the initial velocity at room temperature. Time courses of CypA-catalyzed cis/trans isomerization are shown by dose in Figure 1A . As expected, a mutant CypA lacked PPIase activity (data not shown). This system has a cooled CCD camera imaging system that simultaneously collects the signals from each well of the microplate; a monitoring system that can detect signals at subsecond intervals, enabling kinetic measurements; and an integrated pipetter that may be programmed to inject liquid with shaking of the plate during signal collection. These attributes allowed us to establish HTS using this assay.
Furthermore, we demonstrated that the system was suitable for determination of kinetic parameters. And we determined the K m value of the peptide substrate, Suc-Ala-Ala-Pro-Phe-MCA, as 59 µM by using the Hanes-Woolf plot (Fig. 1B) . The IC 50 value of CsA was determined to be 27 nM (Fig. 1C) , in agreement with reported values. 13 Another feature of this system is that it can nearly detect the initial velocity of PPIase activity. However, the Z′ factor did not stabilize until 2.5 s after initiation of the reaction ( Fig. 2A) . It was preferable to measure initial velocity of PPIase activity, but to perform the HTS campaign, we needed precision to detect true inhibitors. At a measuring time of 1.5 s, the IC 50 value of CsA was determined to be 11 nM (Fig. 2B) . On the other hand, the reaction rates measured at 4.5 s after initiation of the reaction were over 80% (Fig. 1A) , which is far from the initial velocity, and the IC 50 values of CsA also increased.
A measuring time of 2.5 s met the demands of both IC 50 (27 nM) and Z′ factor (>0.8). The ratio of the trans conformation of peptidyl proline in the substrate was about 40% at first. The ratio reached about 70% at 2.5 s, which suggests that about 30% of the cis-proline in the substrate was converted to trans form by the enzyme catalysis. According to Wu et al., 14 the 60% substrate conversion should have little effects on the detection of a weak inhibitor that has an IC 50 value of around 10 µM.
SPR analysis to determine the dissociation constant, KD
To confirm the binding of inhibitors to CypA, we used SPR. Approximately 2000 RU of purified GST-CypA was captured by anti-GST antibody covalently immobilized on the CM5 sensor surface (see Materials and Methods). We next measured the affinity of CsA for the immobilized GST-CypA. Various concentrations of CsA were applied to the sensor, and the naturally occurring tight binding was observed (Fig. 3A, signal  line) . The signals were globally fitted to the kinetic model (Fig. 3A , smooth line), in which a 1:1 complex of GST-CypA and CsA was formed, giving an equilibrium dissociation constant (K D ) of 20.7 nM. The curve plotted as the steady-state response versus the concentration of CsA (Fig. 3B) gave an apparent K D of 28.4 nM. The K D for CsD was determined to be 139 nM at curve fitting and 131 nM at steady state, respectively. CsH, which differs from CsA by substitution of the l-methyl valine at position 11 with its d-isomer, did not bind to CypA ( Table 1) . The corresponding results of the IC 50 and the K D value of the steady-state model well met with each other. GST-CypA immobilized on the surface of the CM5 chip retained 50% of its activity for more than 1 day and showed the same response to CsA and a highly stable baseline.
Validation of the real-time PPIase assay
Three types of cyclosporin (CsA, CsD, and CsH) were examined by the chymotrypsin-coupled PPIase assay and SPR analysis. The IC 50 and K D values are summarized in Table 1 . The IC 50 values of CsA and CsD were 27 and 166 nM, respectively. The K D values determined by SPR were 20.7 and 139 nM, respectively. CsH did not inhibit CypA activity and showed significantly lower affinity to CypA. The IC 50 values of the CsA analogs determined experimentally by the FDSS6000 are in agreement with the K D values obtained by SPR analysis as well as previously reported values. 13, 15 
HTS of small-molecule inhibitors for CypA
Using this method, we were able to measure 40 plates/day and screened several hundred thousand compounds in our chemical library for candidate PPIase inhibitors in a high-throughput manner. One of the typical controls of the assay quality was shown in Figure 4A . In terms of precision, the coefficient of variation (CV) of the conversion ratio of the substrate of 16 repetitive measurements was within 1%. Moreover, Z′ factors of each plate (Fig. 4B) were stabilized during the assay, and the average Z′ factor was 0.8. Hits (>50% inhibition) were retested by a dose-response manner, and these data were fitted with a standard dose-response inhibition model and their IC 50 estimated.
The hit (>50% inhibition) rate was very low (0.11%), but we identified a few relatively potent inhibitors of small molecular mass; these compounds may represent new scaffolds for additional classes of the PPIase inhibitor. The IC 50 values of candidate Cyp inhibitors obtained by this assay were in excellent agreement, with a K D value determined by SPR analyses (Fig. 3C) . More important, they are small molecules less than 1000 molecular masses and not cyclic peptide like CsA derivatives, but they bind to the same site as CsA determined by the SPR competition assay of CsA. CsA and other competitive inhibitors showed the excellent correlation between IC 50 and K D . This observation is thought to be useful for probing a novel CypA inhibitor. Despite the rapid conversion of substrates, we determined an appropriate (about 50%) substrate conversion ratio that should lead to this HTS success. 
